Platforms for Personalized Polytherapeutics Discovery in COVID-19.
Platforms for Personalized Polytherapeutics Discovery in COVID-19.
复制标题
DOI:
10.1016/j.jmb.2021.166945
复制
发表时间:
2021-05-14
影响因子:
5.6
通讯作者:
Freeman WD
中科院分区:
文献类型:
--
作者:
Hopkins C;Onweni C;Zambito V;Fairweather D;McCormick K;Ebihara H;Caulfield T;Zhang YS;Freeman WD
The COVID-19 pandemic entered its third and most intense to date wave of infections in November 2020. This perspective article describes how combination therapies (polytherapeutics) are a needed focus for helping battle the severity of complications from SARS-CoV-2 infection. It outlines the types of systems that are needed for fast and efficient combinatorial assessment of therapeutic candidates. Proposed are micro-physiological systems using human iPSC as a format for tissue-specific modeling of infection, the use of gene-humanized zebrafish and C. elegans for combinatorial drug screens due to the animals being addressable in liquid multi-well formats, and the use of engineered pseudo-typing systems to safely model infection in the transgenic animals and engineered tissue systems.
登录
查看更多内容
影响因子:
5.2
作者:
Adachi A;Miura T
通讯作者:
Miura T
影响因子:
5
作者:
Almazán F;Sola I;Zuñiga S;Marquez-Jurado S;Morales L;Becares M;Enjuanes L
通讯作者:
Enjuanes L
影响因子:
7.7
作者:
Dye BR;Hill DR;Ferguson MA;Tsai YH;Nagy MS;Dyal R;Wells JM;Mayhew CN;Nattiv R;Klein OD;White ES;Deutsch GH;Spence JR
通讯作者:
Spence JR
影响因子:
64.8
作者:
Dinnon KH 3rd;Leist SR;Schäfer A;Edwards CE;Martinez DR;Montgomery SA;West A;Yount BL Jr;Hou YJ;Adams LE;Gully KL;Brown AJ;Huang E;Bryant MD;Choong IC;Glenn JS;Gralinski LE;Sheahan TP;Baric RS
通讯作者:
Baric RS
DOI:
10.1177/0333102420965157
发表时间:
2020-11
期刊:
Cephalalgia : an international journal of headache
影响因子:
--
作者:
Caronna E;Ballvé A;Llauradó A;Gallardo VJ;Ariton DM;Lallana S;López Maza S;Olivé Gadea M;Quibus L;Restrepo JL;Rodrigo-Gisbert M;Vilaseca A;Hernandez Gonzalez M;Martinez Gallo M;Alpuente A;Torres-Ferrus M;Pujol Borrell R;Alvarez-Sabin J;Pozo-Rosich P
通讯作者:
Pozo-Rosich P